Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their full informed consent before any study-related procedures begin
- People who are 20 years of age or older
- People who have been diagnosed with small cell lung cancer, confirmed through laboratory testing of tissue or cell samples
- People whose physical functioning falls within a certain range, meaning they are able to carry out at least some daily activities (confirm with trial site for exact fitness level required)
- People who are currently receiving or have previously received platinum-based chemotherapy as their first treatment for this cancer
- People who either have stored tissue samples available for laboratory analysis, or who have agreed to have a biopsy taken for that purpose
Who may not be able to join:
- People who have received more than two different chemotherapy treatment courses for small cell lung cancer
- Women who are pregnant or breastfeeding; women who could become pregnant would need to agree to use an effective form of contraception
- People who have a second type of cancer, with limited exceptions — those exceptions include certain treated skin cancers, successfully treated early-stage cervical cancer, or other solid cancers that were fully treated with no signs of return within the last two years (confirm with trial site for exact details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Se-Hoon Lee, MD, PhD, Samsung Medical Center
Phone: +82-10-4759-7640
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ratio of each molecular subtypes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.